These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31278648)

  • 1. Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry.
    Nishimoto Y; Yamashita Y; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    J Thromb Thrombolysis; 2019 Nov; 48(4):587-595. PubMed ID: 31278648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.
    Mohan PP; Manov JJ; Contreras F; Langston ME; Doshi MH; Narayanan G
    Vasc Endovascular Surg; 2018 Apr; 52(3):195-201. PubMed ID: 29436310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
    Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
    Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Eight-year, Single-center Experience on Ultrasound Assisted Thrombolysis with Moderate-dose, Slow-infusion Regimen in Pulmonary Embolism.
    Kaymaz C; Akbal OY; Keskin B; Tokgoz HC; Hakgor A; Karagoz A; Tanyeri S; Kultursay B; Kulahcioglu S; Dogan C; Bayram Z; Efe SÇ; Erkılınç A; Tanboga IH; Akbulut M; Ozdemir N; Tapson V; Konstantinides S
    Curr Vasc Pharmacol; 2022; 20(4):370-378. PubMed ID: 36324223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator dose and pulmonary artery pressure reduction in catheter directed thrombolysis of submassive pulmonary embolism.
    Patel DC; Gaba RC; Liu L; Lokken RP
    PLoS One; 2019; 14(2):e0211701. PubMed ID: 30726288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice patterns and complication rates of thrombolysis for pulmonary embolism.
    Bradford MA; Lindenauer PK; Walkey AJ
    J Thromb Thrombolysis; 2016 Oct; 42(3):313-21. PubMed ID: 26961258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Matsuo R; Kamouchi M; Ago T; Hata J; Shono Y; Kuroda J; Wakisaka Y; Sugimori H; Kitazono T;
    Geriatr Gerontol Int; 2014 Oct; 14(4):954-9. PubMed ID: 24320947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational investigation of thrombolysis with the tissue-type plasminogen activator monteplase for acute pulmonary embolism in Japan.
    Niwa A; Nakamura M; Harada N; Musha T
    Circ J; 2012; 76(10):2471-80. PubMed ID: 22785619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.
    Mikkola KM; Patel SR; Parker JA; Grodstein F; Goldhaber SZ
    Am Heart J; 1997 Jul; 134(1):69-72. PubMed ID: 9266785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the VTE-BLEED score's long-term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry.
    Nishimoto Y; Yamashita Y; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
    J Thromb Haemost; 2020 Mar; 18(3):624-632. PubMed ID: 31785073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of unsuccessful thrombolysis in acute massive pulmonary embolism.
    Meneveau N; Séronde MF; Blonde MC; Legalery P; Didier-Petit K; Briand F; Caulfield F; Schiele F; Bernard Y; Bassand JP
    Chest; 2006 Apr; 129(4):1043-50. PubMed ID: 16608956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective comparison of ultrasound facilitated catheter-directed thrombolysis and systemically administered half-dose thrombolysis in treatment of pulmonary embolism.
    Sharifi M; Awdisho A; Schroeder B; Jiménez J; Iyer P; Bay C
    Vasc Med; 2019 Apr; 24(2):103-109. PubMed ID: 30834822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.
    Ouriel K; Gray B; Clair DG; Olin J
    J Vasc Interv Radiol; 2000 Mar; 11(3):295-8. PubMed ID: 10735422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism　- From the COMMAND VTE Registry.
    Yoshikawa Y; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
    Circ J; 2019 Jun; 83(7):1581-1589. PubMed ID: 31142685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.
    Kucher N; Boekstegers P; Müller OJ; Kupatt C; Beyer-Westendorf J; Heitzer T; Tebbe U; Horstkotte J; Müller R; Blessing E; Greif M; Lange P; Hoffmann RT; Werth S; Barmeyer A; Härtel D; Grünwald H; Empen K; Baumgartner I
    Circulation; 2014 Jan; 129(4):479-86. PubMed ID: 24226805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary practice patterns and outcomes of systemic thrombolysis in acute pulmonary embolism.
    Gayen S; Katz A; Dikengil F; Kwok B; Zheng M; Goldenberg R; Jamin C; Yuriditsky E; Bashir R; Lakhter V; Panaro J; Cohen G; Mohrien K; Rali P; Brosnahan SB
    J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):1119-1127. PubMed ID: 35714905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
    Goldhaber SZ; Kessler CM; Heit JA; Elliott CG; Friedenberg WR; Heiselman DE; Wilson DB; Parker JA; Bennett D; Feldstein ML
    J Am Coll Cardiol; 1992 Jul; 20(1):24-30. PubMed ID: 1607532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolysis during cardio-pulmonary resuscitation].
    Wetsch WA; Spöhr F; Teschendorf P; Böttiger BW; Padosch SA
    Dtsch Med Wochenschr; 2010 Oct; 135(40):1983-8. PubMed ID: 20922642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.